Marie Reveiller-Buffier Email & Phone Number

Caluire Et Cuire, Fr

At 3-D Matrix, we own an unique technology: the self-assembling peptides. We use it as a platform for various applications: in surgery as hemostatic agent, in tissue regeneration and as a drug delivery system. On the market since 2015 in Europe, we have acquired a specific know-how on manufacturing and long-proven the safety of this technology on patients.Our R&D pipeline: wound healing in GI and skin, Inflammatory Bowel Disease, hemostasis in neurosurgery, bone regeneration, drug delivery system.Management of a team of 16 people accross 3 departments: R&D, Regulatory and Quality Affairs, Operation and Supply.- MDR certification of our class III medical device- Set-up a new manufacturing line at subcontractor for double sourcing and scaling-up- Improvement of the process organization of the supply chain and sales order

Caluire Et Cuire, Fr

Create and lead the European R&D department of 5 persons accross product develoment, clinical affairs and external collaboration. - Set-up of Design Control process- Set-up of fist-in-human clinical trial in neurosurgery- Major improvement of production yield- Research & development of wound healing applications- Manufacturing: change of sterilization and improvement of yield

Caluire Et Cuire, Fr

Manage scientific collaborations with research lab, surgeons, biotech companies to develop new applications of 3-D Matrix peptides.Definition of the company strategy of external collaboration:- Management of KOL relationship - Spray development for hydrogel- Proof of concept in cartilage regeneration- Mucosal lifting solution for gastrointestinal resection- IP 4 patent application

Caluire Et Cuire, Fr

Set-up collaborations with academic labs and surgeons for the development of new products in tissue regeneration and drug delivery: - Pre-clinical studies on pigs demonstrating the role of RADA16 on preventing esophageal stenosis- Hydrogel nanoparticles delivery of drug in inflammatory bowell disease- Coordination of post-market clinical trials with a CRO

New York, Ny, Us

Studying the role of the microbiome on the progression of Barrett’s esophagus and adenocarcinoma.

Rochester, Ny, Us

Studying the role of bile acids in the development of Barrett's esophagus and adenocarcinoma. Outcome: 4 publications.

Villeurbanne, Fr

Studying apoptosis resistance mechanism in relation with hormonal status in prostate (collaborations with AstraZeneca and clinicians).Outcome: 2 publications.

Phd, Cancer Biology & Endocrinology

From Idea To Ipo - The Technology Venture